New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

In a trial, the daily GLP-1 pill showed "meaningful weight loss" and similar side effects to injectable GLP-1 drugs like ...

Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

A$350 genetic test developed by Mayo Clinic and Phenomic Sciences may help determine good candidates for GLP-1 anti-obesity drugs like Wegovy or Ozempic.

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically significant, meaning it could have been due to chance – but an earlier study also ...

Novo to test if GLP-1 weight loss drugs can help curb addiction Mar. 06, 2025 6:21 AM ET Novo Nordisk A/S (NVO) Stock, NONOF Stock By: Dulan Lokuwithana, SA News Editor 5 Comments Play (1min) ...

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

Employers are about to spend a lot more on health insurance next year as they shoulder higher costs driven by GLP-1 drugs, ...

Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose ...